Factor XIII-A subunit Val34Leu polymorphism is associated with the risk of thrombosis in patients with antiphospholipid antibodies and high fibrinogen levels - de la Red, G; Tassies, D; Espinosa, G (Thromb Haemost, 2009)
et al.